All filters
Meeting Report
Meeting Report Day 1 | S. Khoo | by M. Mascolini
Presented at:
International Workshop on Clinical Pharmacology of HIV, Hepatitis and Other Antiviral Drugs 2021
Meeting Report
Meeting Report Day 1 | N. Sheehan | by M. Mascolini
Presented at:
International Workshop on Clinical Pharmacology of HIV, Hepatitis and Other Antiviral Drugs 2021
Meeting Report
Meeting Report Day 1 | L. Walker | by M. Mascolini
Presented at:
International Workshop on Clinical Pharmacology of HIV, Hepatitis and Other Antiviral Drugs 2021
Meeting Report
Meeting Report Day 1 | D. Hodge | by M. Mascolini
Presented at:
International Workshop on Clinical Pharmacology of HIV, Hepatitis and Other Antiviral Drugs 2021
Abstracts
Key Considerations for the Introduction of Hepatitis B Birth Dose Vaccine in Cameroon
D. Kamga
Presented at:
Conference on Liver Disease in Africa (COLDA) 2021
Abstracts
A Community of Practice for the Introduction and Scale-up of Hepatitis B Birth Dose Vaccination in Africa: Challenges, Opportunities, and Lessons Learned
H. Njuguna
Presented at:
Conference on Liver Disease in Africa (COLDA) 2021
Abstracts
Hépatite Delta au Senegal
M. Balkissa
Presented at:
Conference on Liver Disease in Africa (COLDA) 2021
Abstracts
Long Term Follow up of Chronic Hepatitis B Cohort in Africa; The Prolifica Gambia Exprience
I. Mahmoud
Presented at:
Conference on Liver Disease in Africa (COLDA) 2021
Abstracts
Assessment of Fibrosis Markers in HEPSANET: A Collaborative Network of Hepatitis B Cohorts in Sub-Saharan Africa
A. Johannessen
Presented at:
Conference on Liver Disease in Africa (COLDA) 2021
Abstracts
Age Cohort Screening for Hepatocellular Carcinoma in an African Population
J. Makpu
Presented at:
Conference on Liver Disease in Africa (COLDA) 2021
Abstracts
Velpatasvir-Based Regimens in Treatment-Naïve and Treatment-Experienced Adults with Resistant Hepatitis C Virus Genotype 4 Subtypes Endemic to Sub-Saharan Africa: Findings from the SHARED-3 Study in Rwanda
F. Shumbusho
Presented at:
Conference on Liver Disease in Africa (COLDA) 2021
Abstracts
Values and Preferences for Hepatitis C Self-Testing Among the General Population and Healthcare Workers in Rwanda
J. Serumondo
Presented at:
Conference on Liver Disease in Africa (COLDA) 2021
Abstracts
EILF-Italian Migrants Study: an HCV and HBV Micro Elimination Pilot Project
G. Colucci
Presented at:
Conference on Liver Disease in Africa (COLDA) 2021
Abstracts
Genedrive® Point of Care Qualitative Testing in a Pilot Hepatitis C Treatment Program
V. Hechter
Presented at:
Conference on Liver Disease in Africa (COLDA) 2021
Abstracts
"Have a Heart, Save My Liver! Who Has Access to the Cure in Africa?"
J. Dountio
Presented at:
Conference on Liver Disease in Africa (COLDA) 2021
Abstracts
Challenges Facing Hepatitis B Infected Population During the COVID-19 Crisis: An Egyptian Survey-Based Questionnaire Study Research
M. Essam
Presented at:
Conference on Liver Disease in Africa (COLDA) 2021
Abstracts
Reduced Hepatitis Screening During Lockdown, a Threat to Global Hepatitis Elimination Target
A. Setofunmi
Presented at:
Conference on Liver Disease in Africa (COLDA) 2021
Abstracts
Impacts de la COVID-19 sur la Prévention, les Soins et le Traitement de L’Hépatite, du VIH et de la Syphilis Chez les Femmes Enceintes dans le District Sanitaire de Baskuy à Ouagadougou
N.A. Guingane
Presented at:
Conference on Liver Disease in Africa (COLDA) 2021
Abstracts
Nonalcoholic Fatty Liver Disease and Severity of COVID-19 Disease Depending on the Plasminogen Activator Inhibitor -1-675 Gene Polymorphism
N. Virstyuk
Presented at:
Conference on Liver Disease in Africa (COLDA) 2021
Abstracts
COVID-19 Resilience at Livewell Initiative LWI
A. Fajimi
Presented at:
Conference on Liver Disease in Africa (COLDA) 2021